Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 6/20 | 0.49 |
| ▸ | DRD3 | P35462 | 6/20 | 0.49 |
| ▸ | DRD4 | P21917 | 4/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22200752 | 0.81 | DRD2 (0.54) | DRD2DRD3DRD4 | |
| SCHEMBL18338393 | 0.75 | DRD2 (0.54) | DRD2DRD3DRD4 | |
| SCHEMBL19043844 | 0.72 | IDO1 (0.40) | DRD2DRD3DRD4 | |
| SCHEMBL19043836 | 0.72 | IDO1 (0.40) | DRD2DRD3DRD4 | |
| SCHEMBL24035779 | 0.72 | DRD2 (0.50) | DRD2DRD3DRD4 | |
| SCHEMBL23283159 | 0.72 | DRD2 (0.50) | DRD2DRD3DRD4 | |
| SCHEMBL25086430 | 0.71 | DRD2 (0.50) | DRD2DRD3DRD4 | |
| SCHEMBL21672105 | 0.71 | DRD2 (0.50) | DRD2DRD3DRD4 | |
| SCHEMBL22200763 | 0.71 | DRD2 (0.57) | DRD2DRD3DRD4 | |
| SCHEMBL21267634 | 0.71 | DRD2 (0.40) | DRD2DRD3DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226113-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | KUMQUAT BIOSCIENCES INC. | 2024-07-11 | — | — | US | disclosed |
| US-20240226113-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | KUMQUAT BIOSCIENCES INC. | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240226113-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | TP53, HRAS, KRAS | DRD2 4829/4885DRD3 4820/4885DRD4 4813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.